Structure

Physi-Chem Properties

Molecular Weight:  652.16
Volume:  593.063
LogP:  0.815
LogD:  0.058
LogS:  -4.493
# Rotatable Bonds:  8
TPSA:  275.5
# H-Bond Aceptor:  17
# H-Bond Donor:  9
# Rings:  5
# Heavy Atoms:  17

MedChem Properties

QED Drug-Likeness Score:  0.108
Synthetic Accessibility Score:  4.853
Fsp3:  0.448
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.47
MDCK Permeability:  4.4134601921541616e-05
Pgp-inhibitor:  0.015
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.829
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.04
Plasma Protein Binding (PPB):  84.93936920166016%
Volume Distribution (VD):  0.613
Pgp-substrate:  19.853084564208984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.102
CYP1A2-substrate:  0.033
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.048
CYP2C9-inhibitor:  0.043
CYP2C9-substrate:  0.161
CYP2D6-inhibitor:  0.121
CYP2D6-substrate:  0.13
CYP3A4-inhibitor:  0.105
CYP3A4-substrate:  0.007

ADMET: Excretion

Clearance (CL):  1.36
Half-life (T1/2):  0.798

ADMET: Toxicity

hERG Blockers:  0.247
Human Hepatotoxicity (H-HT):  0.15
Drug-inuced Liver Injury (DILI):  0.983
AMES Toxicity:  0.847
Rat Oral Acute Toxicity:  0.029
Maximum Recommended Daily Dose:  0.007
Skin Sensitization:  0.892
Carcinogencity:  0.046
Eye Corrosion:  0.003
Eye Irritation:  0.346
Respiratory Toxicity:  0.019

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471669

Natural Product ID:  NPC471669
Common Name*:   [(2R,3R,4R,5R,6S)-6-[(2S,3R,4S,5R,6S)-6-[2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxochromen-3-Yl]Oxy-4,5-Dihydroxy-2-Methyloxan-3-Yl]Oxy-3,4,5-Trihydroxyoxan-2-Yl]Methyl Acetate
IUPAC Name:   [(2R,3R,4R,5R,6S)-6-[(2S,3R,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl acetate
Synonyms:  
Standard InCHIKey:  AATRYBSLZLJIJX-FNBLAZGBSA-N
Standard InCHI:  InChI=1S/C29H32O17/c1-9-25(45-29-23(39)21(37)19(35)17(44-29)8-41-10(2)30)22(38)24(40)28(42-9)46-27-20(36)18-15(34)6-12(31)7-16(18)43-26(27)11-3-4-13(32)14(33)5-11/h3-7,9,17,19,21-25,28-29,31-35,37-40H,8H2,1-2H3/t9-,17+,19-,21+,22-,23+,24+,25-,28-,29-/m0/s1
SMILES:  CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)OC5C(C(C(C(O5)COC(=O)C)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL309225
PubChem CID:   44460558
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003531] Flavonoid-3-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33513 hydrangeae dulcis folium Species n.a. n.a. n.a. n.a. n.a. PMID[11549443]
NPO33513 hydrangeae dulcis folium Species n.a. n.a. n.a. n.a. n.a. PMID[9871657]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 65.4 ng ml-1 PMID[568670]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 52.1 ng ml-1 PMID[568670]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 40.3 ng ml-1 PMID[568670]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Activity = 27.4 ng ml-1 PMID[568670]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471669 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC89127
0.9939 High Similarity NPC173837
0.9878 High Similarity NPC473862
0.9817 High Similarity NPC16194
0.9817 High Similarity NPC473327
0.9817 High Similarity NPC19108
0.9817 High Similarity NPC476472
0.9817 High Similarity NPC253685
0.9817 High Similarity NPC220173
0.9817 High Similarity NPC294815
0.9816 High Similarity NPC471725
0.9816 High Similarity NPC203259
0.9816 High Similarity NPC33054
0.9816 High Similarity NPC134532
0.9816 High Similarity NPC176740
0.9816 High Similarity NPC155877
0.9816 High Similarity NPC471748
0.976 High Similarity NPC470446
0.976 High Similarity NPC241781
0.976 High Similarity NPC470449
0.976 High Similarity NPC162394
0.976 High Similarity NPC470445
0.976 High Similarity NPC156785
0.976 High Similarity NPC470447
0.9758 High Similarity NPC122467
0.9758 High Similarity NPC14187
0.9758 High Similarity NPC202908
0.9758 High Similarity NPC292019
0.9755 High Similarity NPC29958
0.9755 High Similarity NPC67105
0.9755 High Similarity NPC156869
0.9755 High Similarity NPC136042
0.9755 High Similarity NPC116864
0.9755 High Similarity NPC244776
0.9755 High Similarity NPC67326
0.9755 High Similarity NPC259896
0.9755 High Similarity NPC254855
0.9755 High Similarity NPC255157
0.9755 High Similarity NPC95866
0.9702 High Similarity NPC275977
0.9702 High Similarity NPC470455
0.9702 High Similarity NPC470451
0.9702 High Similarity NPC470713
0.9702 High Similarity NPC223860
0.9702 High Similarity NPC249560
0.9702 High Similarity NPC25946
0.9702 High Similarity NPC470720
0.9702 High Similarity NPC21359
0.9702 High Similarity NPC470717
0.9702 High Similarity NPC460984
0.9699 High Similarity NPC89052
0.9699 High Similarity NPC251417
0.9695 High Similarity NPC175107
0.9695 High Similarity NPC153755
0.9695 High Similarity NPC26230
0.9695 High Similarity NPC190003
0.9695 High Similarity NPC60735
0.9693 High Similarity NPC227508
0.9645 High Similarity NPC295625
0.9645 High Similarity NPC473554
0.9645 High Similarity NPC470719
0.9645 High Similarity NPC33083
0.9643 High Similarity NPC470718
0.9641 High Similarity NPC110941
0.9641 High Similarity NPC470443
0.9641 High Similarity NPC126784
0.9641 High Similarity NPC473682
0.9641 High Similarity NPC473571
0.9641 High Similarity NPC241423
0.9641 High Similarity NPC192539
0.9641 High Similarity NPC470444
0.9639 High Similarity NPC219043
0.9639 High Similarity NPC65563
0.9639 High Similarity NPC48984
0.9639 High Similarity NPC470949
0.9636 High Similarity NPC4390
0.9634 High Similarity NPC285197
0.9634 High Similarity NPC155763
0.9634 High Similarity NPC235260
0.9634 High Similarity NPC20505
0.9632 High Similarity NPC275454
0.9632 High Similarity NPC52550
0.9632 High Similarity NPC84362
0.9632 High Similarity NPC223424
0.9632 High Similarity NPC317489
0.9632 High Similarity NPC173637
0.9632 High Similarity NPC127546
0.9588 High Similarity NPC97817
0.9588 High Similarity NPC72554
0.9588 High Similarity NPC30011
0.9581 High Similarity NPC120952
0.9581 High Similarity NPC113836
0.9581 High Similarity NPC139571
0.9581 High Similarity NPC253521
0.9581 High Similarity NPC293626
0.9581 High Similarity NPC217520
0.9581 High Similarity NPC196127
0.9581 High Similarity NPC37668
0.9581 High Similarity NPC258044
0.9581 High Similarity NPC35167
0.9581 High Similarity NPC217387
0.9581 High Similarity NPC267680
0.9578 High Similarity NPC294629
0.9578 High Similarity NPC223426
0.9578 High Similarity NPC81042
0.9578 High Similarity NPC214621
0.9578 High Similarity NPC34267
0.9573 High Similarity NPC138927
0.9573 High Similarity NPC120099
0.9573 High Similarity NPC225434
0.9573 High Similarity NPC270578
0.9573 High Similarity NPC219904
0.9573 High Similarity NPC195257
0.9573 High Similarity NPC86008
0.9573 High Similarity NPC209296
0.9573 High Similarity NPC203050
0.9573 High Similarity NPC52382
0.9573 High Similarity NPC223747
0.9571 High Similarity NPC308404
0.9571 High Similarity NPC64425
0.9571 High Similarity NPC113968
0.9571 High Similarity NPC276222
0.9571 High Similarity NPC210073
0.9571 High Similarity NPC73855
0.9571 High Similarity NPC274618
0.9571 High Similarity NPC145038
0.9571 High Similarity NPC88789
0.9571 High Similarity NPC118284
0.9571 High Similarity NPC281131
0.9571 High Similarity NPC8856
0.9571 High Similarity NPC135599
0.9571 High Similarity NPC56077
0.9571 High Similarity NPC115674
0.9571 High Similarity NPC277174
0.9571 High Similarity NPC179950
0.9571 High Similarity NPC253662
0.9571 High Similarity NPC328940
0.9529 High Similarity NPC474093
0.9529 High Similarity NPC104910
0.9527 High Similarity NPC473072
0.9521 High Similarity NPC8573
0.9521 High Similarity NPC61904
0.9521 High Similarity NPC472385
0.9521 High Similarity NPC169733
0.9521 High Similarity NPC198324
0.9521 High Similarity NPC144097
0.9515 High Similarity NPC206123
0.9512 High Similarity NPC265530
0.9512 High Similarity NPC325555
0.9512 High Similarity NPC226304
0.9512 High Similarity NPC160156
0.9512 High Similarity NPC92565
0.9509 High Similarity NPC277205
0.9509 High Similarity NPC55786
0.9509 High Similarity NPC19388
0.9509 High Similarity NPC240431
0.9474 High Similarity NPC475179
0.9471 High Similarity NPC148710
0.9467 High Similarity NPC473071
0.9467 High Similarity NPC473073
0.9464 High Similarity NPC477895
0.9461 High Similarity NPC210094
0.9461 High Similarity NPC101191
0.9461 High Similarity NPC237435
0.9461 High Similarity NPC198199
0.9461 High Similarity NPC477848
0.9461 High Similarity NPC115760
0.9461 High Similarity NPC264735
0.9461 High Similarity NPC49344
0.9461 High Similarity NPC135277
0.9461 High Similarity NPC43211
0.9458 High Similarity NPC180918
0.9458 High Similarity NPC245452
0.9455 High Similarity NPC105283
0.9455 High Similarity NPC43587
0.9451 High Similarity NPC197285
0.9451 High Similarity NPC21100
0.9448 High Similarity NPC19709
0.9412 High Similarity NPC135831
0.9412 High Similarity NPC97119
0.9412 High Similarity NPC36138
0.9412 High Similarity NPC297503
0.9405 High Similarity NPC472384
0.9405 High Similarity NPC268533
0.9405 High Similarity NPC472382
0.9405 High Similarity NPC233994
0.9405 High Similarity NPC211532
0.9405 High Similarity NPC472380
0.9401 High Similarity NPC21666
0.9401 High Similarity NPC24043
0.9401 High Similarity NPC208668
0.9401 High Similarity NPC204693
0.9401 High Similarity NPC169977
0.9401 High Similarity NPC101026
0.9401 High Similarity NPC472993
0.9401 High Similarity NPC42773
0.9401 High Similarity NPC45522
0.9401 High Similarity NPC25724
0.9398 High Similarity NPC218488
0.9398 High Similarity NPC44328

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471669 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9877 High Similarity NPD7251 Discontinued
0.9816 High Similarity NPD6797 Phase 2
0.9697 High Similarity NPD7808 Phase 3
0.9634 High Similarity NPD7472 Approved
0.9573 High Similarity NPD7054 Approved
0.9461 High Similarity NPD4338 Clinical (unspecified phase)
0.9398 High Similarity NPD7074 Phase 3
0.9222 High Similarity NPD7804 Clinical (unspecified phase)
0.9042 High Similarity NPD6166 Phase 2
0.9042 High Similarity NPD6168 Clinical (unspecified phase)
0.9042 High Similarity NPD6167 Clinical (unspecified phase)
0.8935 High Similarity NPD3818 Discontinued
0.8909 High Similarity NPD4381 Clinical (unspecified phase)
0.8902 High Similarity NPD3817 Phase 2
0.8683 High Similarity NPD7075 Discontinued
0.8671 High Similarity NPD7993 Clinical (unspecified phase)
0.8667 High Similarity NPD1934 Approved
0.8614 High Similarity NPD2393 Clinical (unspecified phase)
0.8528 High Similarity NPD1512 Approved
0.8512 High Similarity NPD3882 Suspended
0.8512 High Similarity NPD4868 Clinical (unspecified phase)
0.8503 High Similarity NPD7096 Clinical (unspecified phase)
0.8503 High Similarity NPD2801 Approved
0.8452 Intermediate Similarity NPD5402 Approved
0.8443 Intermediate Similarity NPD6801 Discontinued
0.8405 Intermediate Similarity NPD1511 Approved
0.8364 Intermediate Similarity NPD5403 Approved
0.8323 Intermediate Similarity NPD4380 Phase 2
0.8305 Intermediate Similarity NPD6559 Discontinued
0.8297 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD6799 Approved
0.8242 Intermediate Similarity NPD5401 Approved
0.8133 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8111 Intermediate Similarity NPD8313 Approved
0.8111 Intermediate Similarity NPD8312 Approved
0.8095 Intermediate Similarity NPD1653 Approved
0.8079 Intermediate Similarity NPD7228 Approved
0.807 Intermediate Similarity NPD7819 Suspended
0.8 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD7685 Pre-registration
0.7978 Intermediate Similarity NPD3751 Discontinued
0.7965 Intermediate Similarity NPD1465 Phase 2
0.7955 Intermediate Similarity NPD3787 Discontinued
0.7953 Intermediate Similarity NPD7411 Suspended
0.7943 Intermediate Similarity NPD5494 Approved
0.7933 Intermediate Similarity NPD5844 Phase 1
0.7927 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7266 Discontinued
0.7927 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7921 Intermediate Similarity NPD7473 Discontinued
0.7919 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.791 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6959 Discontinued
0.7879 Intermediate Similarity NPD1549 Phase 2
0.7865 Intermediate Similarity NPD7435 Discontinued
0.7861 Intermediate Similarity NPD8455 Phase 2
0.7853 Intermediate Similarity NPD6232 Discontinued
0.7846 Intermediate Similarity NPD8151 Discontinued
0.7826 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD7199 Phase 2
0.7796 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD919 Approved
0.7765 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD2796 Approved
0.7738 Intermediate Similarity NPD6190 Approved
0.7706 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7705 Intermediate Similarity NPD7240 Approved
0.7697 Intermediate Similarity NPD1510 Phase 2
0.7684 Intermediate Similarity NPD6234 Discontinued
0.7679 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7626 Intermediate Similarity NPD7874 Approved
0.7626 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7617 Intermediate Similarity NPD6776 Approved
0.7617 Intermediate Similarity NPD6781 Approved
0.7617 Intermediate Similarity NPD6780 Approved
0.7617 Intermediate Similarity NPD6779 Approved
0.7617 Intermediate Similarity NPD6782 Approved
0.7617 Intermediate Similarity NPD6778 Approved
0.7617 Intermediate Similarity NPD6777 Approved
0.76 Intermediate Similarity NPD37 Approved
0.759 Intermediate Similarity NPD7698 Approved
0.759 Intermediate Similarity NPD7696 Phase 3
0.759 Intermediate Similarity NPD7697 Approved
0.7588 Intermediate Similarity NPD7783 Phase 2
0.7588 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD3750 Approved
0.7571 Intermediate Similarity NPD4966 Approved
0.7571 Intermediate Similarity NPD4965 Approved
0.7571 Intermediate Similarity NPD4967 Phase 2
0.7571 Intermediate Similarity NPD7768 Phase 2
0.7563 Intermediate Similarity NPD7584 Approved
0.7561 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1613 Approved
0.7551 Intermediate Similarity NPD8320 Phase 1
0.7551 Intermediate Similarity NPD8319 Approved
0.7546 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD7701 Phase 2
0.7515 Intermediate Similarity NPD1933 Approved
0.7515 Intermediate Similarity NPD230 Phase 1
0.75 Intermediate Similarity NPD1247 Approved
0.7471 Intermediate Similarity NPD4628 Phase 3
0.7462 Intermediate Similarity NPD7870 Phase 2
0.7462 Intermediate Similarity NPD7871 Phase 2
0.7455 Intermediate Similarity NPD1240 Approved
0.744 Intermediate Similarity NPD1551 Phase 2
0.743 Intermediate Similarity NPD3749 Approved
0.7423 Intermediate Similarity NPD7699 Phase 2
0.7423 Intermediate Similarity NPD7700 Phase 2
0.7418 Intermediate Similarity NPD3926 Phase 2
0.7407 Intermediate Similarity NPD8150 Discontinued
0.7407 Intermediate Similarity NPD8434 Phase 2
0.7377 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD1607 Approved
0.7358 Intermediate Similarity NPD6535 Approved
0.7358 Intermediate Similarity NPD6534 Approved
0.735 Intermediate Similarity NPD7585 Approved
0.7349 Intermediate Similarity NPD943 Approved
0.7337 Intermediate Similarity NPD2935 Discontinued
0.733 Intermediate Similarity NPD7458 Discontinued
0.7327 Intermediate Similarity NPD7801 Approved
0.7317 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD447 Suspended
0.73 Intermediate Similarity NPD7583 Approved
0.7299 Intermediate Similarity NPD2533 Approved
0.7299 Intermediate Similarity NPD2534 Approved
0.7299 Intermediate Similarity NPD2532 Approved
0.7296 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD3748 Approved
0.7273 Intermediate Similarity NPD3027 Phase 3
0.7273 Intermediate Similarity NPD6823 Phase 2
0.726 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7236 Intermediate Similarity NPD7680 Approved
0.7229 Intermediate Similarity NPD6798 Discontinued
0.7216 Intermediate Similarity NPD920 Approved
0.7212 Intermediate Similarity NPD6832 Phase 2
0.7202 Intermediate Similarity NPD6355 Discontinued
0.72 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6233 Phase 2
0.7181 Intermediate Similarity NPD5953 Discontinued
0.7176 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7033 Discontinued
0.7166 Intermediate Similarity NPD7286 Phase 2
0.7135 Intermediate Similarity NPD3226 Approved
0.711 Intermediate Similarity NPD1243 Approved
0.711 Intermediate Similarity NPD1652 Phase 2
0.7102 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7085 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6099 Approved
0.7035 Intermediate Similarity NPD6100 Approved
0.7033 Intermediate Similarity NPD5353 Approved
0.703 Intermediate Similarity NPD1203 Approved
0.7024 Intermediate Similarity NPD2313 Discontinued
0.7017 Intermediate Similarity NPD6844 Discontinued
0.7016 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD2800 Approved
0.7011 Intermediate Similarity NPD6674 Discontinued
0.7005 Intermediate Similarity NPD4363 Phase 3
0.7005 Intermediate Similarity NPD4360 Phase 2
0.7 Intermediate Similarity NPD5124 Phase 1
0.7 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.6994 Remote Similarity NPD2346 Discontinued
0.6994 Remote Similarity NPD1091 Approved
0.6977 Remote Similarity NPD2799 Discontinued
0.6971 Remote Similarity NPD7930 Approved
0.6961 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6651 Approved
0.6954 Remote Similarity NPD6212 Phase 3
0.6954 Remote Similarity NPD6213 Phase 3
0.6954 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6949 Remote Similarity NPD7390 Discontinued
0.6944 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6941 Remote Similarity NPD4060 Phase 1
0.6935 Remote Similarity NPD8127 Discontinued
0.6923 Remote Similarity NPD3268 Approved
0.6919 Remote Similarity NPD7097 Phase 1
0.6905 Remote Similarity NPD4908 Phase 1
0.6898 Remote Similarity NPD5711 Approved
0.6898 Remote Similarity NPD5710 Approved
0.689 Remote Similarity NPD422 Phase 1
0.6886 Remote Similarity NPD2798 Approved
0.6882 Remote Similarity NPD4062 Phase 3
0.6868 Remote Similarity NPD6386 Approved
0.6868 Remote Similarity NPD6385 Approved
0.6867 Remote Similarity NPD3225 Approved
0.6864 Remote Similarity NPD7095 Approved
0.6862 Remote Similarity NPD5242 Approved
0.6856 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6848 Remote Similarity NPD9269 Phase 2
0.6848 Remote Similarity NPD9717 Approved
0.6847 Remote Similarity NPD5006 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data